Association Between Chronic PM2.5 Exposure and CT-Detected Lung Abnormalities in the SPIROMICS Cohort [0.03%]
慢性细颗粒物暴露与SPIROMICS队列中CT检测到的肺异常之间的关联关系研究
Christopher B Bosma,Lantian Xu,Susan Murray et al.
Christopher B Bosma et al.
Rationale: Air pollution contributes additively to COPD morbidity beyond tobacco exposure. Limited current data focuses on the impact of fine particulate matter ≤ 2.5 µm in aerodynamic diameter (PM2.5) on COPD pathogene...
Amanda Grant-Orser,Daniel-Costin Marinescu,Cameron J Hague et al.
Amanda Grant-Orser et al.
Rationale: Familial pulmonary fibrosis (FPF), defined as fibrosing interstitial lung disease (ILD) affecting two or more family members, is associated with earlier-onset and a more aggressive disease phenotype. Imaging fi...
Insurance and Treatment Patterns in Pulmonary Arterial Hypertension: The Pulmonary Hypertension Association Registry [0.03%]
肺动脉高压的保险和治疗模式：肺动脉高压协会注册处数据的研究
Breanne E McCarthy,Rui Feng,Roberto Bernardo et al.
Breanne E McCarthy et al.
Rationale: Pulmonary arterial hypertension (PAH) medications are costly for patients and often subject to insurance-related restrictions that may limit access. The impact of insurance type on PAH treatment has not been st...
Inhaler Technique in Chronic Obstructive Pulmonary Disease: Patient Impairments and Bronchodilation [0.03%]
慢性阻塞性肺疾病患者吸入剂使用手法、患者吸收能力及支气管舒张调查研究
Donald A Mahler,Sergio Martinez,Thomas M Siler et al.
Donald A Mahler et al.
Rationale: Despite worldwide use of handheld delivery systems in the treatment of chronic obstructive pulmonary disease (COPD), evidence is limited about how patient factors affect inhaler technique with each device type....
Reply to ishii et al.: clarifying the association between sedative selection and outcomes in ARDS: Methodological considerations [0.03%]
对ishii等人的回复：ARDS中镇静剂选择与预后之间关联的方法学考虑及澄清
Peter J Dunbar,Ryan A Peterson,Max McGrath et al.
Peter J Dunbar et al.
Fine particulate matter exposure and Cystic Fibrosis morbidity in the age of CFTR modulators, an observational study [0.03%]
CFTR调节剂时代精细颗粒物暴露与囊性纤维化发病率的观察研究
Jelte Kelchtermans,Joseph M Collaco,Sharon A McGrath-Morrow et al.
Jelte Kelchtermans et al.
Rationale: Despite CFTR modulators transforming cystic fibrosis (CF) care, patients still show wide variability in pulmonary outcomes. The contribution of ambient fine particulate matter (PM2.5) exposure to this variabili...
EBRT and Interventions for Malignant Central Airway Obstruction: A False Dichotomy [0.03%]
恶性中央气道阻塞的体外放射治疗与介入治疗：一种错误的二分法？
Jacob Schwartz,Gabriel Ortiz,Dagny Anderson et al.
Jacob Schwartz et al.
Persistent Dyspnea in COVID-19 Survivors without Structural Cardiopulmonary Disease: Multidimensional Phenotyping at 4 Years [0.03%]
新冠肺炎康复者四年随访无结构性心肺疾病的持续呼吸困难的多维度表型分析
Pauliane Vieira Santana,Pedro Caruso,Carlos Roberto Ribeiro de Carvalho
Pauliane Vieira Santana
Rationale: Persistent dyspnea despite normal cardiopulmonary structure is a frequent but poorly understood long-term sequela of COVID-19. Scant data exist on the multidimensional clinical profiles that underlie dyspnea in...
Establishing Scope of Practice: National Trends in Tracheobronchial Stenting for Central Airway Obstruction [0.03%]
支架治疗中心气道阻塞的国家趋势及界定适应证
Yan Ming Zhou,Kai E Swenson
Yan Ming Zhou
Reply to Schwartz: EBRT and Interventions for Malignant Central Airway Obstruction: A False Dichotomy [0.03%]
回复施瓦茨：恶性中央气道阻塞的放疗与介入：一种错误的二分法观点回应文章
Roshen Mathew,Nikhil Meena,Levent Dalar
Roshen Mathew